This month, the December 2012 issue of the Open Rheumatology Journal published an online article from a group that was brought together for a meeting in Aachen, Germany by Grünenthal GmbH, a pharmaceutical company. The authors were compensated for their time and had assistance in the writing of the publication, which was funded by Grünenthal.
The article describes osteoarthritis and rheumatoid arthritis, as well as multiple therapies. It concludes that the use of combinations of medications, as well as a multimechanistic approach are what is needed to help avoid the long-term potential safety concerns associated with NSAIDs.
No comments:
Post a Comment